Terumo (OTCMKTS:TRUMY) Releases Quarterly Earnings Results

Terumo (OTCMKTS:TRUMY) released its earnings results on Wednesday. The company reported $0.16 earnings per share (EPS) for the quarter, Zacks reports. Terumo had a return on equity of 9.19% and a net margin of 12.09%.

Terumo Stock Down 3.0%

TRUMY stock traded down $0.50 during mid-day trading on Wednesday, reaching $15.89. The company had a trading volume of 38,504 shares, compared to its average volume of 158,047. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.64 and a quick ratio of 1.53. The stock has a 50 day simple moving average of $16.73 and a two-hundred day simple moving average of $17.60. The company has a market capitalization of $23.52 billion, a price-to-earnings ratio of 27.87 and a beta of 0.77. Terumo has a 52 week low of $15.47 and a 52 week high of $21.22.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.